GRPR-Antagonists Carrying DOTAGA-Chelator via Positively Charged Linkers: Perspectives for Prostate Cancer Theranostics

Gastrin-releasing peptide receptor (GRPR)-antagonists have served as motifs in the development of theranostic radioligands for prostate cancer. Our efforts have been focused on the development of radiolabeled RM26 (H-DPhe⁶–Gln⁷–Trp⁸–Ala⁹–Val¹⁰–G...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Karim Obeid, Panagiotis Kanellopoulos, Ayman Abouzayed, Adam Mattsson, Vladimir Tolmachev, Berthold A. Nock, Theodosia Maina, Anna Orlova
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	MDPI AG 2024-04-01
Edice:	Pharmaceutics
Témata:	prostate cancer GRPR GRPR-antagonist radiotheranostics PC-3 cell/tumor neprilysin
On-line přístup:	https://www.mdpi.com/1999-4923/16/4/513
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!